A Study of TAK-079 in People With Generalized Myasthenia Gravis

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

July 12, 2022

Study Completion Date

July 12, 2022

Conditions
Myasthenia Gravis
Interventions
DRUG

TAK-079

TAK-079 subcutaneous injection

DRUG

TAK-079 Placebo

TAK-079 placebo-matching subcutaneous injection

Trial Locations (50)

10021

Hospital For Special Surgery, New York

11000

Clinical Center of Serbia - PPDS, Belgrade

Military Medical Academy, Belgrade

16132

IRCCS AOU San Martino, Genova

18000

Clinical Center Nis, Niš

20037

George Washington University, Washington D.C.

20133

Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta, Milan

27514

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

28007

Hospital General Universitario Gregorio Maranon, Madrid

28040

Hospital Clinico San Carlos, Madrid

28046

Hospital Universitario La Paz - PPDS, Madrid

28207

Carolinas HealthCare System Neurosciences Institute-Neurology, Charlotte

30912

Augusta University, Augusta

32751

Neurology Associates PA, Maitland

33487

SFM Clinical Research, LLC, Boca Raton

33952

Medsol Clinical Research Center Inc, Port Charlotte

41009

Hospital Universitario Virgen Macarena, Seville

43210

Ohio State University Medical Center, Columbus

45267

University of Cincinnati, Cincinnati

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

48201

Wayne State University, Detroit

48202

Henry Ford Health System, Detroit

48824

Michigan State University, East Lansing

50139

Azienda Ospedaliera Universitaria Careggi, Florence

53215

Center for Neurological Disorders, Milwaukee

53226

The Medical College of Wisconsin, Inc., Milwaukee

60062

Consultants In Neurology, Northbrook

65212

Neurology and Sleep Disorders Clinic, Columbia

66160

University of Kansas Medical Center, Kansas City

75390

The University of Texas South Western Medical Center, Dallas

78681

Central Texas Neurology Consultants PA, Round Rock

78756

Austin Neuromuscular Center, Austin

80045

University of Colorado Hospital, Aurora

85713

The University of Arizona Medical Center, Tucson

94304

Stanford Neuroscience Health Center, Palo Alto

95816

University of California Davis Medical Center, Sacramento

95817

University of California Davis Medical Center, Sacramento

T3M 1M4

The Governors of the University of Calgary, Calgary

V6E2E3

Vancouver General Hospital (VGH), Vancouver

M5G 2C4

Toronto General Hospital, Toronto

00168

Fondazione Policlinico Universitario A Gemelli, Rome

00189

Azienda Ospedaliera Sant'andrea, Rome

85-796

Neurocentrum Bydgoszcz sp. z o.o., Bydgoszcz

31-505

Centrum Neurologii Klinicznej Sp. z o.o., Krakow

01-684

Centrum Medyczne NeuroProtect, Warsaw

01-868

Centrum Medyczne Warszawa - PRATIA - PPDS, Warsaw

03010

Hospital General Universitario de Alicante, Alicante

08035

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

08041

Hospital de La Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04159805 - A Study of TAK-079 in People With Generalized Myasthenia Gravis | Biotech Hunter | Biotech Hunter